Scandinavian Real Heart AB (Publ)

Stockholm Stock Exchange:HEART.ST

Sector

🏥 Health Care

Industries

💊 Pharmaceuticals

🧬 Biotechnology

Location

Sweden

Market Cap

USD 3.34 M

Share Price

USD 1.55

Avg Daily Volume

7,333

Change (1 day)

7.25%

Change (1 year)

-47.72%

Change (YTD)

44.82%

Scandinavian Real Heart AB (Publ) Revenue for the year ending December 31, 2024: USD 0.00

Scandinavian Real Heart AB (Publ) Revenue is USD 0.00 for the year ending December 31, 2024. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.

Scandinavian Real Heart AB (Publ) Revenue for the year ending December 31, 2023 was USD 0.00, a -100.00% change year over year.
Scandinavian Real Heart AB (Publ) Revenue for the year ending December 31, 2022 was USD 955.00.
Scandinavian Real Heart AB (Publ) Revenue for the year ending December 31, 2021 was USD 0.00.
Scandinavian Real Heart AB (Publ) Revenue for the year ending December 31, 2020 was USD 0.00.

Quarterly
Annual
TTM

From:

To:

Zoom:

1Y
3Y
5Y
10Y
15Y
20Y
Max

Key data

Date	Revenue	Revenue	Gross Profit	Operating Income

Stockholm Stock Exchange: HEART.ST

Scandinavian Real Heart AB (Publ)

CEO	Dr. Ina Laura Perkins
IPO Date	Nov. 26, 2014
Location	Sweden
Headquarters	Kopparbergsvägen 6
Employees	13
Sector	🏥 Health Care
Industries Pharmaceuticals 🧬 Biotechnology

Description

Scandinavian Real Heart AB (Publ) designs and develops an artificial heart. It engages in developing Realheart TAH to treat advanced stage heart failure. It also develops RealVAD, PulsePump, and Sternal Prosthesis products. The company was incorporated in 2007 and is based in Västerås, Sweden.

Similar companies

Novo Nordisk A/S

USD 73.32

-2.33%

AbbVie Inc.

USD 185.30

-0.10%

Roche Holding AG

USD 336.78

-0.52%

Abbott Laboratories

USD 132.99

0.44%

Novartis AG

USD 115.96

-0.50%

AstraZeneca PLC

USD 140.24

-1.30%

Merck & Co., Inc.

USD 79.06

-0.29%

Amgen Inc.

USD 289.33

-0.10%

Pfizer Inc.

USD 23.97

0.38%

Gilead Sciences, Inc.

USD 108.50

0.46%

Sanofi

USD 95.88

0.36%

Vertex Pharmaceuticals Incorporated

USD 440.87

-1.68%

Bristol-Myers Squibb Company

USD 46.86

0.04%

Chugai Pharmaceutical Co., Ltd.

USD 49.19

-0.68%

GSK plc

USD 18.89

-2.25%

CSL Limited

USD 154.82

0.08%

Zoetis Inc.

USD 157.17

1.36%

Regeneron Pharmaceuticals, Inc.

USD 509.72

-0.75%

MERCK Kommanditgesellschaft auf Aktien

USD 127.08

1.48%

Lonza Group AG

USD 684.56

0.23%

Jiangsu Hengrui Medicine Co., Ltd.

USD 7.23

0.75%

Takeda Pharmaceutical Company Limited

USD 29.34

-0.64%

Alnylam Pharmaceuticals, Inc.

USD 309.70

-0.84%

UCB SA

USD 181.46

0.14%

GE HealthCare Technologies Inc.

USD 71.28

-0.85%

Regencell Bioscience Holdings Limited

USD 38.01

-40.00%

Bayer AG

USD 30.75

-0.65%

Celltrion, Inc.

USD 117.76

1.81%

WuXi AppTec Co., Ltd.

USD 9.39

0.82%

Sandoz Group AG

USD 53.32

-0.10%

Laboratory Corporation of America Holdings

USD 261.88

0.19%

Hansoh Pharmaceutical Group Company Limited

USD 3.57

0.90%

Royalty Pharma plc

USD 34.86

-0.14%

Insmed Incorporated

USD 102.68

3.24%

Biogen Inc.

USD 127.04

0.40%

Astellas Pharma Inc.

USD 9.25

-0.70%

Innovent Biologics, Inc.

USD 9.90

-0.96%

Summit Therapeutics Inc.

USD 20.56

1.98%

Shionogi & Co., Ltd.

USD 17.12

0.25%

Genmab A/S

USD 212.20

-1.53%

Neurocrine Biosciences, Inc.

USD 126.55

-0.60%

WuXi Biologics (Cayman) Inc.

USD 3.07

0.00%

Torrent Pharmaceuticals Limited

USD 36.56

0.20%

Tempus AI, Inc.

USD 68.31

-1.14%

Exelixis, Inc.

USD 40.37

-0.91%

Mankind Pharma Limited

USD 26.42

-1.47%

Beijing Wantai Biological Pharmacy Enterprise Co., Ltd.

USD 8.66

2.02%

BioMarin Pharmaceutical Inc.

USD 55.00

-0.43%

Ascendis Pharma A/S

USD 176.90

3.63%

StockViz Staff

June 22, 2025

Any question? Send us an email